Singapore markets closed
Straits Times Index
3,394.21 +17.02 (+0.50%) Nikkei
27,382.56 +19.81 (+0.07%) Hang Seng
22,688.90 +122.12 (+0.54%) FTSE 100
7,765.15 +4.04 (+0.05%) BTC-USD
23,151.76 +55.75 (+0.24%) CMC Crypto 200
526.66 +9.65 (+1.87%)
Cyclerion Therapeutics, Inc. (CYCN)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
| Previous close | 0.6903 |
| Open | 0.7066 |
| Bid | 0.6700 x 900 |
| Ask | 0.7000 x 2900 |
| Day's range | 0.6599 - 0.7066 |
| 52-week range | 0.3500 - 1.4900 |
| Volume | |
| Avg. volume | 161,352 |
| Market cap | 29.211M |
| Beta (5Y monthly) | 2.05 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.2350 |
| Earnings date | 24 Feb 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 4.00 |
- Zacks
Cyclerion Therapeutics, Inc. (CYCN) Reports Q2 Loss, Misses Revenue Estimates
Cyclerion Therapeutics, Inc. (CYCN) delivered earnings and revenue surprises of 8.82% and 56.90%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2023 Yahoo. All rights reserved.
